FindMyRecallSubscribe
Class I: serious health riskTerminated

Mylan Institutional Gemcitabine for Injection Recall

Gemcitabine for Injection, USP, 200 mg*/vial, Lyophilized powder in a Single-Use Vial,…

Mylan Institutional LLC · Rockford, IL

Risk level
Class I
Reported by FDA
Aug 26, 2015
Recall ID
D-1332-2015
Check your lot numberHow we source this data

Summary

Mylan Institutional recalled Gemcitabine for Injection starting Mar 23, 2015. The FDA classified it as Class I (serious health risk) and published enforcement report D-1332-2015 on Aug 26, 2015. Reason: Presence of Particulate Matter. Status: Terminated.

Why it was recalled

Presence of Particulate Matter

Product description

Gemcitabine for Injection, USP, 200 mg*/vial, Lyophilized powder in a Single-Use Vial, Rx only, labeled as a) Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, Made in India, NDC 67457-464-20, UPC 3 67457 46420 6; and b) Distributed by Pfizer Labs, Division of Pfizer Inc, New York, NY 10017, Made in India, NDC 0069-3857-10, UPC 3 00693 85710 4.

Lot numbers, UPCs & expiration codes

Lot #: a) 7801396, 7801398, 7801401, 7801406, Exp 08/16; 7801427, Exp 09/16; b) 7801089, 7801084, Exp 07/15; 7801110, Exp 08/15

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1332-2015
Classification
Class I
Status
Terminated
Recall initiated
Mar 23, 2015
FDA report date
Aug 26, 2015
Quantity
a) 35,197 vials; b) 21,302 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Mylan Institutional LLC

Original FDA data

Every field from FDA enforcement report D-1332-2015, exactly as published.

Show all FDA fields
City
Rockford
State
IL
Status
Terminated
Country
United States
Event ID
71004
Address
4901 Hiawatha Dr
Code information
Lot #: a) 7801396, 7801398, 7801401, 7801406, Exp 08/16; 7801427, Exp 09/16; b) 7801089, 7801084, Exp 07/15; 7801110, Exp 08/15
Postal code
61103-1287
Report date
Aug 26, 2015
Product type
Drugs
Recall number
D-1332-2015
Classification
Class I
Recalling firm
Mylan Institutional LLC
Product quantity
a) 35,197 vials; b) 21,302 vials
Termination date
May 20, 2016
Reason for recall
Presence of Particulate Matter
Voluntary / mandated
Voluntary: Firm initiated
Product description
Gemcitabine for Injection, USP, 200 mg*/vial, Lyophilized powder in a Single-Use Vial, Rx only, labeled as a) Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, Made in India, NDC 67457-464-20, UPC 3 67457 46420 6; and b) Distributed by Pfizer Labs, Division of Pfizer Inc, New York, NY 10017, Made in India, NDC 0069-3857-10, UPC 3 00693 85710 4.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Mar 23, 2015
Initial firm notification
Letter
Center classification date
Aug 14, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1332-2015, published Aug 26, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls